U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07020559) titled 'Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction: a Randomized Controlled Trial' on June 06.
Brief Summary: Diabetic wounds are difficult to heal. Autologous platelets in diabetic patients with renal insufficiency have poor function. Allogeneic platelet plasma has a promising application prospect. Comparing the efficacy and safety differences between allogeneic platelet plasma and autologous platelet plasma is of significant importance and value for the clinical application.
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Diabetic Wounds
Platelet Rich Plasma
Allogeneic Blood Transfusions
R...